Subchronic Toxicity of Garcinia Xanthochymus Fruit Bark Extract to Female Rats: Effect on Liver and Kidney
DOI:
https://doi.org/10.22270/ajprd.v13i3.1567Abstract
Nanostructured Lipid Carriers (NLCs) are nanoscale colloidal systems developed for drug delivery, featuring a core composed of solid and liquid lipids. These lipid-based carriers have emerged as biocompatible, non-toxic, and safer alternatives to polymeric and metallic nanoparticles. Their advantageous properties—such as improved safety, physical stability, and higher drug-loading capacity compared to other lipid-based nanocarriers—have attracted significant interest from researchers aiming to develop efficient and reliable drug delivery systems. NLCs enhance the solubility and permeability of therapeutic agents by encapsulating them within a lipid matrix, making them suitable for administration via challenging biological routes. Furthermore, surface functionalization and the incorporation of specific excipients can enhance targeted delivery and extend systemic circulation. Owing to these features, NLCs hold great potential in the treatment of various conditions, including cancer, infectious diseases, neurodegenerative disorders, hypertension, diabetes, and chronic pain. This review provides a comprehensive analysis of NLCs, focusing on their structural components, fabrication techniques, characterization methods, formulation strategies, and applications in pharmaceutical and therapeutic contexts, particularly in targeted drug delivery systems.
Downloads
References
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1-2):170-84.
Subramaniam B, Siddik ZH, Nagoor NH. Optimization of nanostructured lipid carriers: understanding the types, designs, and parameters in the process of formulations. J Nanopart Res. 2020;22:141.
Lüdtke FL, Silva TJ, da Silva MG, Hashimoto JC, Ribeiro APB. Lipid nanoparticles: formulation, production methods and characterization protocols. Foods. 2025;14:973.
Puri A, Loomis K, Smith B, Lee JH, Yavlovich A, Heldman E, et al. Lipid-based nanoparticles as pharmaceutical drug carriers: from concepts to clinic. Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80.
Ghasemiyeh P, Mohammadi-Samani S. Solid lipid nanoparticles and nanostructured lipid carriers as novel drug delivery systems: applications, advantages and disadvantages. Res Pharm Sci. 2018;13(4):288-303.
Khan S, Sharma A, Jain V. An overview of nanostructured lipid carriers and its application in drug delivery through different routes. Adv Pharm Bull. 2023;13(3):446-60.
Vairo C, Collantes M, Quincoces G, Villullas S, Peñuelas I, Pastor M, et al. Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies. Int J Pharm. 2019;569:118484.
Elmowafy M, Al-Sanea MM. Nanostructured lipid carriers (NLCs) as drug delivery platform: advances in formulation and delivery strategies. Saudi Pharm J. 2021;29(9):999-1012.
Karn-Orachai K, Smith SM, Phunpee S, Treethong A, Puttipipatkhachorn S, Pratontep S, et al. The effect of surfactant composition on the chemical and structural properties of nanostructured lipid carriers. J Microencapsul. 2014;31(6):609-18.
Haider M, Abdin SM, Kamal L, Orive G. Nanostructured lipid carriers for delivery of chemotherapeutics: a review. Pharmaceutics. 2020;12(3):288.
Nandvikar N, Lala R, Shinde A. Nanostructured lipid carrier: the advanced lipid carriers. Int J Pharm Sci Res. 2019;10(12):5252-65.
Gomaa E, Fathi HA, Eissa NG, Elsabahy M. Methods for preparation of nanostructured lipid carriers. Methods. 2022;199:3-8.
Stefanov SR, Andonova VY. Lipid nanoparticulate drug delivery systems: recent advances in the treatment of skin disorders. Pharmaceuticals. 2021;14:1083.
Nagaich U, Gulati N. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Drug Deliv Transl Res. 2016;6:289-298.
Bhuyan C, Saha D, Rabha B. A brief review on topical gels as drug delivery system. J Pharm Res Int. 2021 Oct 26;33:344-57.
Wathoni N, Suhandi C, Elamin KM, Lesmana R, Hasan N, Mohamined AFA, et al. Advancements and challenges of nanostructured lipid carriers for wound healing applications. Int J Nanomed. 2024;19:8091-8113.
Tapfumaneyi P, Mohammad I, Yousuf M, Roberts MS. Recent advances and future prospective of topical and transdermal delivery systems. Front Drug Deliv. 2022;2.
Nerli G, Gonçalves LMD, Cirri M, Almeida AJ, Maestrelli F, Mennini N, et al. Design, evaluation and comparison of nanostructured lipid carriers and chitosan nanoparticles as carriers of poorly soluble drugs. Pharmaceutics. 2023;15:1305.
Shinde C, Venkatesh MP, Pramod Kumar T, Pai DR. Nanostructured lipid carrier-based smart gel: a delivery platform for intra-articular therapeutics. Autoimmunity. 2020;54(1):35-44.
Rapalli VK, Kaul V, Waghule T, Gorantla S, Sharma S, Roy A, et al. Curcumin loaded nanostructured lipid carriers for enhanced skin retained topical delivery. Eur J Pharm Sci. 2020;152:105438.
Agrawal YO, Mahajan UB, Mahajan HS, Ojha S. Methotrexate-loaded nanostructured lipid carrier gel alleviates imiquimod-induced psoriasis. Int J Nanomed. 2020;15:4763-78.
Iqbal MA, Md S, Sahni JK, Baboota S, Dang S, Ali J. Nanostructured lipid carriers system: recent advances in drug delivery. J Drug Target. 2012;20(10):813-30.
Han F, Yin R, Che X, Yuan J, Cui Y, Yin H, et al. Nanostructured lipid carriers (NLC) based topical gel of flurbiprofen: design, characterization and in vivo evaluation. Int J Pharm. 2012;439(1-2):349-57.
Patel D, Dasgupta S, Dey S, Roja Ramani Y, Ray S, Mazumder B. Nanostructured lipid carriers (NLC)-based gel for the topical delivery of aceclofenac: preparation, characterization, and in-vivo evaluation. Scientia Pharmaceutica. 2012;80(3):749-64.
Fernandes AV, Pydi CR, Verma R, Jose J, Kumar L. Design, preparation and in vitro characterizations of fluconazole loaded nanostructured lipid carriers. Braz J Pharm Sci. 2020;56.
Pawbake GR, Shirolkar SV. Formulation, development and evaluation of nanostructured lipid carrier (NLC) based gel for topical delivery of diacerein. Syst Rev Pharm. 2020;11(6):794-802.
Agarwal S, Kumar SH, Garg R. Investigative study on impact of solid: liquid lipid ratio and stabilizer amount on some characteristics of nanostructure lipid carriers of quetiapine fumarate. Int J Pharm Investig. 2019;9(2):47-52.
Madan JR, Khobaragade S, Dua K, Awasthi R. Formulation, optimization and in-vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast. Dermatol Ther. 2020;33(3):e13370.
Ni S, Sun R, Zhao G, Xia Q. Quercetin loaded nanostructured lipid carrier for food fortification: preparation, characterization and in-vitro study. J Food Process Eng. 2015;38:93-106.
Fathi HA, Allam A, Elsabahy M, Fetih G, El-Badry M. Nanostructured lipid carriers for improved oral delivery and prolonged antihyperlipidemic effect of simvastatin. Colloids Surf B Biointerfaces. 2018;162:236-45.
Mishra A, Imam SS, Aqil M, Ahad A, Sultana Y, Ameeduzzafar, Ali A. Carvedilol nano lipid carriers: formulation, characterization and in-vivo evaluation. Drug Deliv. 2016;23(4):1486-94.
Teng Z, Yu M, Ding Y, Zhang H, Shen Y, Jiang M, Liu P, Opoku-Damoah Y, Webster TJ, Zhou J. Preparation and characterization of nimodipine-loaded nanostructured lipid systems for enhanced solubility and bioavailability. Int J Nanomed. 2019;14:119.
Fang G, Tang B, Chao Y, Zhang Y, Xu H and Tang X:Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, invivo evaluation and intestinal transport studies. RSC Advances 2015; 5(117): 96437-47.
Fahmy UA, Ahmed OA, Badr-Eldin SM, Aldawsari HM, Okbazghi SZ, Awan ZA, Bakhrebah MA, Alomary MN, Abdulaal WH, Medina C, Alhakamy NA. Optimized nanostructured lipid carriers integrated into in situ nasal gel for enhancing brain delivery of flibanserin. Int J Nanomed. 2020;15:5253.
Cunha S, Costa CP, Loureiro JA, Alves J, Peixoto AF, Forbes B, Sousa Lobo JM, Silva AC. Double optimization of rivastigmine-loaded nanostructured lipid carriers (NLC) for nose-to-brain delivery using the quality by design (QbD) approach: formulation variables and instrumental parameters. Pharmaceutics. 2020;12(7):599.
Khosa A, Krishna KV, Dubey SK and Saha RN: Lipid Nanocarriers for Enhanced Delivery of Temozolomide to the Brain. In Drug Delivery Systems 2020; 285-298.
Emami J, Yousefian H, Sadeghi H. Targeted nanostructured lipid carrier for brain delivery of artemisinin: design, preparation, characterization, optimization and cell toxicity. J Pharm Pharm Sci. 2018;21(1):225-41.
Khan SA, Rehman S, Nabi B, Iqubal A, Nehal N, Fahmy UA, Kotta S, Baboota S, Md S, Ali J. Boosting the brain delivery of Atazanavir through nanostructured lipid carrier-based approach for mitigating neuroAIDS. Pharmaceutics. 2020; 12(11):1059.
Dobreva M, Stefanov S, Andonova V. Natural lipids as structural components of solid lipid nanoparticles and nanostructured lipid carriers for topical delivery. Curr Pharm Des. 2020;26(36):4524-35.
Youssef A, Dudhipala N, Majumdar S. Ciprofloxacin loaded nanostructured lipid carriers incorporated into in situ gels to improve management of bacterial endophthalmitis. Pharmaceutics. 2020;12(6):572.
Lakhani P, Patil A, Taskar P, Ashour E, Majumdar S. Curcumin-loaded nanostructured lipid carriers for ocular drug delivery: design optimization and characterization. J Drug Deliv Sci Technol. 2018; 47:159-66.
Varela-Fernández R, García-Otero X, Díaz-Tomé V, Regueiro U, López-López M, González-Barcia M, Lema MI, Otero-Espinar FJ. Lactoferrin-loaded nanostructured lipid carriers (NLCs) as a new formulation for optimized ocular drug delivery. Eur J Pharm Biopharm. 2022; 172:144-56.
L Kiss E, Berkó S, Gácsi A, Kovács A, Katona G, Soós J, Csányi E, Gróf I, Harazin A, Deli MA and Budai-Szűcs M: Design and Optimization of Nanostructured Lipid Carrier Containing Dexamethasone for Ophthalmic Use. Pharmaceutics 2019; 11(12): 679.
Published
How to Cite
Issue
Section
Copyright (c) 2025 Neha S. Ghogare, Dr. Vikrant P. Wankhade, Dr. Shrikant D. Pande, Dr. Sandeep C. Atram, Dr. Nishan N. Bobade, Vikram V. Bhoyar, Tanvi S. Kokate
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
AUTHORS WHO PUBLISH WITH THIS JOURNAL AGREE TO THE FOLLOWING TERMS:
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 Unported License. that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
.